The global diabetes devices market size was USD 30.40 billion in 2023, calculated at USD 32.74 billion in 2024 and is projected to surpass around USD 68.75 billion by 2034, expanding at a CAGR of 7.7% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Diabetes Devices Market, By Type
7.1. Diabetes Devices Market, by Type, 2024-2034
7.1.1. Blood Glucose Monitoring
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Insulin Delivery Devices
7.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 8. Global Diabetes Devices Market, By Application
8.1. Diabetes Devices Market, by Application, 2024-2034
8.1.1. Diagnostic Center
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Home Care
8.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Diabetes Devices Market, By Distribution Channel
9.1. Diabetes Devices Market, by Distribution Channel, 2024-2034
9.1.1. Retail Pharmacy
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Hospital Pharmacy
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Clinics
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Online Pharmacy
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Diabetes Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2021-2034)
10.1.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.1.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.5.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
Chapter 11. Company Profiles
11.1. B Braun Melsungen AG
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbott Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bayer AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Medtronic Plc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. F.Hoffman-La-Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Lifescan, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Dexcom, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Sanofi
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Tandem Diabetes Care, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Companion Medical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample